Introduction
Visual function has important role in the
quality of life especially for older individuals.(1-2) Elderly
patients have increased risk of developing chronic illnesses that may affect
their life style and necessitate physical and health care. Their condition may
dramatically worsen if they develop visual impairment and blindness.(3)
In Western countries, visual impairment and blindness are common in
elderly population with clinically significant increase in the prevalence of
visual impairment with advancing age.(4-6) Most of the cases
are attributed to age related macular degeneration.(7-8)
In our area, we have less life expectancy than in the Western community;
therefore the causes of visual impairment differ. It is important to know the cause of blindness
as some of the illnesses are treatable such as cataract and some of them if treated
at early stage blindness can be prevented such as glaucoma and diabetic
retinopathy. Other causes can be simple and treated by glasses such as presbyopia. Age-related macular degeneration
remains the main cause of irreversible loss of vision in the elderly in the Western countries.(9) With
recent advances in treatment options, blindness can be prevented in some cases.
The aim of our study was to investigate the causes of visual impairment and
blindness among elderly patients in Jordan. Amman city was taken as an example where 40%
of Jordanian population lives. In addition, King
Hussein Medical
Center is considered as a tertiary
referral center for patients from different cities in Jordan.
Methods
A prospective study that was conducted at King Hussein
Medical Center
of the Royal Medical Services during the period between January 2010 and
January 2012. Approval of the ethical committee was taken. Inclusion criteria were
patients older than 60 years of age attending ophthalmology clinic for any
complaint with best corrected visual acuity of less than 6/18 in the better
eye. Patients were classified into two groups: first group included patients
with visual impairment defined by best corrected visual acuity of less than
6/18 and better than 3/60 in the better eye, and second group included blind
patients with best corrected visual acuity of less than 3/60 in the better eye
(according to World Health Organization of visual impairment and blindness).(10)
Ophthalmologic examination included best
corrected visual acuity by Snellen’s chart, anterior segment examination via
slit lamp biomicroscopy, intraocular pressure assessment by Goldmann’s
applanation tonometry and posterior segment examination slit lamp biomicroscopy
using +78 non-contact lens. Causes of visual
impairment and blindness were investigated for all patients. The main cause of
visual impairment or blindness was considered to be the cause of visual loss.
If the main cause of visual loss was not clear then mixed diagnoses were
considered. Descriptive statistical methods (frequency, percentage) were used
to describe the study variables.
Results
One thousand and two hundred and forty patients
were enrolled in the study. Male to female ratio was 1.1:1. Age range was 60.3
years to 89.7 years. Nine hundreds and eighty nine patients (79.8%) had visual
impairment and 251 patients (20.2%) were blind according to WHO criteria of
visual impairment and blindness. Cataract was the main cause of visual
impairment and blindness (51.7% and 9.8% respectively, Table I). Table II shows
number of patients with visual impairment and blindness according to age,
gender and their illness. The second
cause of visual impairment was diabetic retinopathy followed by glaucoma and
age related macular degeneration (Table III) whereas the later was the second
cause of blindness (Table IV). Other causes included corneal and myopic
degenerations, optic nerve disease and retinal and vascular pathologies.
Discussion
Our study was a hospital based study that was
conducted at King Hussein Medical
Center which is a tertiary referral
center and receives patients from all over Jordan. This makes the results of our
study almost similar to a population based one rather than a hospital based
one. However, we still expect to find some differences for incidence of visual
impairment and blindness in patients attending a clinic from those in the
general population. The presence of medical illness was not considered an
exclusion criterion in our study. For example, diabetes mellitus was considered
a major cause of blindness either by causing cataract or diabetic retinopathy.
The main cause of visual impairment or blindness was considered to be the cause
of visual loss. If the main cause of
visual loss was not clear then mixed diagnoses were considered. Other causes
secondary to medical illness included vascular insults related to hypertension
and hyperlipidemia.
Causes
of visual impairment and blindness differ between age groups. For young
patients common causes include refractive errors and related
disorders such as amblyopia and retinal problems, diabetic retinopathy, optic
nerve disease and hereditary problems such as retinitis pigmentosa.(11)
In elderly patients, cataract and age related macular degenerations are
the leading cause of blindness worldwide with the later being common in Western
countries.(12) Elderly patients have more risk to develop
chronic medical illnesses and may require special medical care. With visual
impairment, they may be rendered handicapped resulting in physical and social
trauma and functional impairment.(13) It is
important to investigate the cause of visual impairment as many conditions could
be treatable if detected at an early stage. In our series, cataract was the
leading cause of visual impairment representing 51.7% of total patients (Table I).
It was followed by age related macular degeneration, glaucoma, and diabetic
retinopathy occurring in 7%, 6.8% and 5.7% respectively. Mixed pathology
occurred in 5.1%. Other causes of visual impairment occurred in 43 cases (3.5%)
that included corneal pathology 17 patients (1.4%), myopic degenerations 14 patients
(1.1%), optic nerve disease seven patients (0.6%), vascular pathologies four
patients (0.3%) and retinal detachment in one patient (0.1%). Regarding
patients with blindness, cataract formed nearly half of patients. Age related
macular degeneration was seen in slightly more than quarter of the cases.
Diabetic retinopathy and glaucoma occurred in 9% and 8% of blind patients
respectively (Table IV). Nine patients (0.7%) had other causes that included
optic nerve pathology (3 patients), retinal detachment (3 patients), corneal
pathology (2 patients) and myopic degeneration in one patient. The fact that
cataract is a treatable disease and vision can be restored explains why it
contributes more to visual impairment group than to blindness group whereas age
related macular degeneration contributes more to blindness group as there are
some types that are refractory to treatment.(14)
There are controversies in literature
regarding the main cause of visual impairment and blindness in elderly
population. This could be partly attributed to the difference in age groups
studies as some studies included patients age above 50 years while others
included patients above 75 years. Other reason of controversy is the definition
of visual impairment and blindness used. Some studies used WHO classification
as we did while others used USA classification which defines visual impairment
as best acuity of less than 6/12 and better than 6/60 and defines blindness as
visual acuity of less than 6/60.(7)
Local hospital based studies like our study
done in Southern and Northern Jordan found
cataract to be the leading cause of blindness followed by diabetic retinopathy
and glaucoma. (15-16) A study done in Saudi Arabia
showed that refractive error is the leading cause of visual impairment followed
by the triad of cataract, diabetic retinopathy and glaucoma.(17) Evans et al. found age related macular
degeneration contributing to 52.9% of visual loss followed by cataract in 35.9%.(18)
The Rotterdam study showed that cataract is the leading cause of visual
impairment while age related macular degeneration is the leading cause of
blindness.(19) Examples of studies that found cataract
contributing more to visual impairment included the Baltimore study,(20)
Blue Mountains Eye study,(21) and Rotterdam study.(18)
Examples of studies that found age
related macular degeneration contributing more to visual impairment included
MRC study,(5) See study,(7) and
Melbourne study.(8) Regarding blindness, MRC, See
and Blue Mountains Eye study found age related macular degeneration to be the
commonest cause followed by glaucoma.
Beaver Dam,(6) Melbourne,
(8) and Rotterdam(19)
studies supported that cataract are causing less causes of blindness. In our
series, cataract is still the leading cause of blindness in our elderly patients
though causing less contribution to blindness group than visually impaired
group. This can be explained by the fact that many cataract patients in our
country present late until they reach the stage of blindness.
In addition, life expectancy in our country is
less than in Western countries; hence less age related macular degeneration
patients. In early 2007, the United Nations Department of Economic and Social Affairs, Population Division, released World Population Prospects, the 2006 Revision which shows life
expectancies in different countries. The life expectancy in Jordan was 72.5
years and was preceded by 88 countries.(22) Age related
macular degeneration is considered a disease of Western countries as it risks
increases with higher life expectancy.(12) Table II shows the number of visually impaired
and blind patients according to their age, gender and illness. Regarding male patients older than 80 years,
age related macular degeneration is a main cause of blindness and visual
impairment. In females older than 80 years, age related macular degeneration
and diabetic retinopathy comes in the second rank after cataract as causes of
blindness and visual impairment (Table II).
In literature, the Rotterdam study showed that persons younger
than 75 years, myopic degeneration and optic neuropathy were the most important
causes of impaired vision and for persons aged 75 years or older; age related
macular degeneration was the major cause of blindness, whereas cataract predominantly
caused visual impairment.(19)
Conclusion
Cataract is the most common cause of visual
impairment and blindness in elderly patients in our hospital. It is a treatable
condition with good potential of visual recovery. Other causes include
glaucoma, diabetic retinopathy and some types of age related macular
degeneration which can be better treated if discovered at an early stage.
References
1.
Lee PP, Spitzer K,
Hays RD. The impact of blurred vision on functioning and
well-being. Ophthalmology 1997; 104: 390-396.
2.
Llewellyn-Jones RH, Baikie KA. Visual impairment and
depression in residential care. Med J Aust 1997; 167: 416.
3.
Adamsons I, Taylor H. Major causes of world
blindness: their treatment and prevention. Curr Opin Ophthalmol. 1990;
1: 635-642.
4.
Van der Pols JC, Bates CJ, McGraw PV, et al. Visual acuity
measurements in a national sample of British elderly people. Br J Ophthalmol
2000; 84: 165-170.
5.
Evans JR, Fletcher AE, Wormald RPL, et al. Prevalence of visual
impairment in people aged 75 years and older in Britain: results from the MRC trial
of assessment and management of older people in the community. Br J
Ophthalmol 2002; 86: 795-800.
6.
Klein R, Klein BEK,
Lee KE. Changes in visual acuity in a population: the
Beaver Dam Eye Study. Ophthalmology 1996; 103: 1169-1178.
7.
Rubin GS, West SK,
Munoz B, et al. A comprehensive
assessment of visual impairment in a population of older Americans: the SEE
Study. Invest Ophthalmol Vis Sci 1997; 38: 557-568.
8.
Taylor HR, Livingstone PM, Stanislavsky YL,
McCarty CA.
Visual impairment in Australia:
distance visual acuity, near vision, and visual field findings of the Melbourne
Visual Impairment Project. Am J Ophthalmol 1997; 123: 328-337.
9.
Visser L. Common eye disorders in
the elderly – a short review. SA Fam Pract 2006; 48: 34-38.
10.
World Health Organization. International
Statistical Classification of Diseases and Related Health Problems, Tenth
Revision. Vol 1. Geneva, Switzerland: World Health
Organization; 1992.
11.
Buch H, Vinding T, La Cour M, et al.
Prevalence and causes of visual impairment and blindness among 9980
Scandinavian adults. Ophthalmology 2004; 111: 53-61.
12. Harvey
PT.
Common eye diseases of
elderly people: identifying and treating causes of vision loss. Gerontology 2003:
49; 1-11.
13.
Crocker HS. Age-related vision loss
in the older adult: the role of the nurse practitioner in prevention and early
detection. Clin Excell Nurse Pract 2001; 5: 185-196.
14. Minassian DC, Reidy A,
Lightstone A, Desai P.
Modelling the prevalence of age-related macular degeneration (2010-2020) in the
UK:
expected impact of anti-vascular endothelial growth factor (VEGF) therapy. Br
J Ophthalmol 2011; 95: 1433-1436.
15. Rawashdeh K, Abu Laban W, Al Madani
M. Causes of blindness among
patients in south Jordan.
JRMS 2006; 13: 23- 26.
16. Haddadin A, Ereifej I, Zawaida F, Haddadin H. Causes of visual impairment and blindness among the middle-aged and elderly in
northern Jordan.
EMHJ 2002; 8: 404-408.
17. Al-Shaaln F, Bakrman M,
Ibrahim A, SrourAljoudi A. Prevalence and causes of visual impairment among Saudi
adults attending primary health care centers in northern Saudi Arabia. Ann Saudi Med 2011; 31: 473–480.
18.
Evans JR, Fletcher AE, Wormald RPL. Causes
of visual impairment in people aged 75 years and older in Britain: an add-on study to the MRC
Trial of assessment and management of older people in the vommunity. BR J
Ophthalmol 2004; 88: 365-370.
19.
Klaver CC, Wolfs RC, Vingerling JR, et al. Age-Specific Prevalence
and Causes of Blindness and Visual Impairment in an Older Population. The Rotterdam Study. Arch
Ophthalmol 1998; 116: 653-658.
20.
Tielsch JM, Javitt JC, Coleman A, et al. The prevalence of
blindness and visual impairment among nursing home residents in Baltimore. N Engl J Med
1995; 332: 1205-1209.
21.
Foran S, Rose K, Wang JJ, Mitchell Pl. Correctable visual
impairment in an older population: the Blue Mountains Eye Study. Am J
Ophthalmol 2002; 134: 712-719.
22. United Nations World Population Prospects: 2006 revision. Availabe from:
http://www.un.org/esa/population/publications/wpp2006/WPP2006_Highlights_rev.pdf.